NPR blog examines debate over option B+ HIV prevention strategy

NewsGuard 100/100 Score

NPR's "Shots" blog examines the debate over Option B+, a strategy to prevent mother-to-child HIV transmission that "aims to put every pregnant woman with HIV on triple-drug treatment and keep her on it for the rest of her life -- even if the virus has not yet damaged her immune system to the point where she needs medications to preserve her own health." A report published Friday in the Centers for Disease Control and Prevention's (CDC) "Morbidity and Mortality Weekly Report" shows "that when Malawi ... made a big push to implement Option B+, the payoff was impressive: a sevenfold increase in the number of pregnant and breastfeeding women starting anti-HIV treatment in only a year," according to the blog. CDC Director Thomas Frieden "estimates Option B+ prevented 7,000 infants from getting HIV from their mothers in its first year of operation," and "[h]e predicts Option B+ will have ripple effects that benefit families and communities by sharply reducing transmission of HIV from women to their uninfected partners," the blog notes.

"But not everyone is convinced," "Shots" writes. Hoosen Coovadia, a leading South African HIV researcher, "tells 'Shots' that he had 'a gut reaction' against Option B+ last July 'because of the way it was presented' at the International AIDS Conference in Washington, D.C.," the blog notes, adding he said, "Almost everyone spoke about B+ as though it was going to change the direction of the AIDS epidemic. But it didn't look to me that there had been adequate consultation. This was a pet program of the U.S. government." The blog continues, "Recently he coauthored a sharply worded commentary in the Lancet calling Option B+ 'extreme,'" and "Shots" notes the authors wrote, "A switch now would be dangerous, ignoring severe ethical, safety, feasibility and economic concerns." The blog adds, "Coovadia calls for more study of Option B+ before implementing it aggressively. More data will be forthcoming. Rwanda and Haiti have already adopted the strategy, and seven other sub-Saharan countries are actively implementing it or preparing to" (Knox, 2/28).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New drug candidates show promise to reverse HIV immune evasion